MedPath

Oral midazolam versus intranasal Dexmedetomidine for CT imaging in children

Phase 3
Completed
Conditions
Pediatric patients visiting hospital for diagnostic CT Imaging
Registration Number
CTRI/2014/03/004456
Lead Sponsor
Post Graduate Institute of Medical Education and Research
Brief Summary

**Infants and children frequently require sedation to prevent motion artifacts during radiological imaging. We compared intranasal dexmedetomidine premedication (2.5mcg/kg) with oral midazolam 0.5 mg/kg for sedation in children undergoing CT imaging. Children were randomized to one of the two groups Group M received 0.5 mg/Kg midazolam and group D received 2.5 mc/Kg intranasal dexmedetomidine. After 20-30 minutes IV line was placed. The child was then transferred to CT table for imaging. Wilton score were observed and noted at that time. According to the level of sedation and scan duration, the child received 0.5 –1mg/Kg I.V ketamine to achieve a level of deep sedation. Any movement, motion artifact or repeat scans reported by radiologist were noted.**

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
48
Inclusion Criteria

ASA I or II children aged 1 – 5 years scheduled for CT imaging under sedation.

Exclusion Criteria

Children with history of allergy to eutectic mixture of local anesthetic (EMLA) cream, midazolam severe dysfunction of central nervous system, malformation of cardiovascular system, children on chronic hepatic enzyme inducing drugs or mentally retarded children.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
incidence of children requiring rescue sedation (IV ketamine)during CT Imaging
Secondary Outcome Measures
NameTimeMethod
incidence of children crying at venipuncture, number of attempts at venipuncture, sedation and venipuncture scores, requirement of ketamine for CT, parental satisfaction, movements and motion artifacts during scan and requirement of repeat scanat venepuncture and during CT imaging

Trial Locations

Locations (1)

Post Graduate Institute of Medical Education and Research

🇮🇳

Chandigarh, CHANDIGARH, India

Post Graduate Institute of Medical Education and Research
🇮🇳Chandigarh, CHANDIGARH, India
Dr Babita Ghai
Principal investigator
09914209533
ghaibabita@hotmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.